-
41
Case Report: Diagnostic itinerary of a male case of juvenile-onset systemic lupus erythematosus in Bouake
Published 2025-02-01“…This case illustrates the shortage of paediatric rheumatologists and marks a breaking point in the diagnosis of the disease, which is sometimes difficult even for practitioners, making it difficult for sick children to access care. …”
Get full text
Article -
42
Drug-induced psoriasis
Published 2019-01-01“…Due to the various systemic comorbidities, patients with psoriasis often receive polypharmacy and hence it is important for dermatologists, rheumatologists, and physicians to be aware of the possible triggers.…”
Get full text
Article -
43
CD19-directed chimeric antigen receptor T-cell therapy: what can we learn from the haematologist?
Published 2025-01-01“…The experiences with CD19 CAR T-cell therapy in haematology may offer valuable insights for immunologists and rheumatologists. This article reviews the key principles learnt in haematology, the results and the mechanisms behind its efficacy, toxicities, and the challenges that need to be addressed for its broader application in clinical practice.…”
Get full text
Article -
44
The Discrepancy of ANA and Compartment Bead Patterns Suggestive of a Neuropsychiatry Systemic Lupus Erythematosus (NPSLE)
Published 2023-01-01“…Neuropsychiatric systemic lupus erythematosus (NPSLE) exhibits neurological and psychiatric manifestations in systemic lupus erythematosus (SLE) patients, which NPSLE diagnosis can be challenging for rheumatologists. An Indonesian female, 44 years old, complained of two times seizures with 10-min duration, which during seizures were stiff, eyes rolled up, foaming at the mouth, wet the bed, and fainting afterward. …”
Get full text
Article -
45
Renal Manifestations of IgG4-Related Disease: A Concise Review
Published 2024-01-01“…This synthesis will be highly relevant for nephrologists, rheumatologists, general internists, and renal pathologists to raise awareness and help improve early recognition of IgG4-related kidney disease (IgG4-RKD).…”
Get full text
Article -
46
The Potential Importance of MicroRNAs as Novel Indicators How to Manage Patients with Juvenile Idiopathic Arthritis More Effectively
Published 2021-01-01“…As they draw increasing attention of rheumatologists, there is a growing body of evidence concerning specific molecules that may affect the long-term care of patients with inflammatory arthritides. …”
Get full text
Article -
47
Behçet’s disease: recurrent ischemic stroke as an initial presentation – a case based review
Published 2025-01-01“…Our case report underscores the difficulties of diagnosing BD with ischemic stroke as the initial manifestation and emphasizes the importance of a multidisciplinary approach that involves rheumatologists, neurologists, and radiologists to create an effective treatment plan. …”
Get full text
Article -
48
Combined case record forms for collating obstetric outcomes in rare rheumatic diseases
Published 2020-01-01“…The forms underwent four rounds of revision by two rheumatologists with trial runs on three patients each. …”
Get full text
Article -
49
Deficiency of Interleukin-1 Receptor Antagonist: A Case with Late Onset Severe Inflammatory Arthritis, Nail Psoriasis with Onychomycosis and Well Responsive to Adalimumab Therapy
Published 2019-01-01“…Therefore, clinical symptoms should be learned exactly by the pediatricians, pediatric rheumatologists, and immunologists; and molecular analysis targeting this defect must be performed as early as possible.…”
Get full text
Article -
50
Vascular cytoprotection, autoimmune disease, and premature atherosclerosis
Published 2018-01-01“…Similarly, close liaison between rheumatologists and cardiologists is essential to minimize the cardiovascular impact on patients and to ensure that patients with rheumatic disease and coexistent coronary heart disease receive appropriate therapy. …”
Get full text
Article -
51
Perceptions of Biosimilars Among Healthcare Providers in Saudi Arabia
Published 2024-11-01“…However, disparities among regulatory authorities, such as the absence of guidelines for biosimilars for rheumatologists, impact healthcare providers' perceptions, leading to hesitation in switching from reference products to biosimilars. …”
Get full text
Article -
52
Acknowledging and addressing real-world challenges to treating immune-related adverse events
Published 2024-07-01“…The latter is complicated by the lack of US Food and Drug Administration-approved irAE treatments that lead to insurance denials, as well as the high cost of biological immunosuppressant therapies. Fortunately, rheumatologists and other subspecialists with expertize in the management of chronic autoimmune conditions have become more involved in irAE diagnosis and management and may help navigate treatment. …”
Get full text
Article -
53
Imaging in connective tissue disease-associated interstitial lung disease
Published 2021-01-01“…Interstitial lung disease (ILD) in rheumatic or connective tissue disease (CTD) is well recognized and presents both diagnostic and management challenges to rheumatologists. Imaging plays a central role in diagnosing and assessing treatment response. …”
Get full text
Article -
54
Picking interstitial lung disease out of the myositis haystack
Published 2020-01-01“…This heterogeneous disease group requires robust multidisciplinary collaboration between rheumatologists, pulmonologists, thoracic radiologists, and histopathologists to bring together clinical assessment to reach a diagnostic conclusion so optimal outcomes can be achieved.…”
Get full text
Article -
55
Influence of Medication on Flare Up and Infection After Elective Orthopedic Surgery in Rheumatoid Arthritis Patient – A Narrative Review
Published 2020-10-01“…Background: Orthopedic Surgery in Rheumatoid Arthritis (RA) patients is still controversial between orthopedic surgeons and rheumatologists, mainly due to infection and disease flares. …”
Get full text
Article -
56
Maternal and Perinatal Outcome in Women with Systemic Lupus Erythematosus: A Retrospective Bicenter Cohort Study
Published 2017-01-01“…Pregnancies > 16 weeks gestation of SLE patients receiving joint care from rheumatologists and gynecologists in two tertiary centers in the Netherlands between 2000 and 2015 were included. …”
Get full text
Article -
57
Key personal insights and changing needs of osteoarthritis patients: an international quantitative survey analysis
Published 2024-12-01“…The cross-country workshop, conducted via Zoom, brought together prominent rheumatologists to discuss the survey results and explore patient support opportunities with healthcare providers. …”
Get full text
Article -
58
Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies
Published 2022-07-01“…ISI/PGA-PsO/PGJS-VAS-PsO improvements from baseline of ≥3/≥2/≥40-mm VAS corresponded with clinically meaningful DLQI improvements; improvements from baseline of ≥4/≥3/≥40-mm VAS generally corresponded with clinically meaningful improvements across component scores and all SF-36v2 domains.Conclusions Substantial links exist between dermatologic symptoms and QoL in patients with PsA, potentially informing patient-centered care and research. Rheumatologists should be aware of dermatologic manifestations and QoL impacts in patients with PsA.ClinicalTrials.gov NCT01877668; NCT01882439…”
Get full text
Article -
59
CHARACTERISTICS OF THE COURSE OF LEUCOCYTOCLASTIC VASCULITIS WITH SKIN LESIONS. ANALYSIS OF CLINICAL CASES
Published 2023-04-01“…Diagnosis and treatment of LCV is a complex problem in the practice of doctors of many specialties, such as rheumatologists, dermatologists, and therapists, family doctors, which requires close cooperation of specialists. …”
Get full text
Article -
60
Challenges in Diagnosis and Management of SLE in Africa: An Online Survey
Published 2025-01-01“…Results Our 226 respondents from 31 countries were dermatologists (38%), rheumatologists (28%), and nephrologists (23%), the majority practicing at university/state‐funded hospitals (80.8%), but over half of patients (59.6%) were self‐funded for laboratory tests and medications. …”
Get full text
Article